Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other financing activities (2020 - 2025)

Maravai Lifesciences Holdings has reported Other financing activities over the past 4 years, most recently at $1.4 million for Q1 2025.

  • Quarterly results put Other financing activities at $1.4 million for Q1 2025, down 42.18% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 10.8% YoY), and the annual figure for FY2025 was $1.4 million, up 10.8%.
  • Other financing activities for Q1 2025 was $1.4 million at Maravai Lifesciences Holdings, up from -$5.8 million in the prior quarter.
  • Over the last five years, Other financing activities for MRVI hit a ceiling of $2.4 million in Q1 2024 and a floor of -$5.8 million in Q4 2024.
  • Median Other financing activities over the past 3 years was $2.0 million (2023), compared with a mean of $976000.0.
  • Peak annual rise in Other financing activities hit 383.33% in 2024, while the deepest fall reached 350.58% in 2024.
  • Maravai Lifesciences Holdings' Other financing activities stood at $2.3 million in 2023, then tumbled by 350.58% to -$5.8 million in 2024, then surged by 123.62% to $1.4 million in 2025.
  • The last three reported values for Other financing activities were $1.4 million (Q1 2025), -$5.8 million (Q4 2024), and $2.3 million (Q3 2024) per Business Quant data.